Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 4 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis.
Mult Scler Relat Disord. 2022 Dec;68:104173. doi: 10.1016/j.msard.2022.104173. Epub 2022 Sep 14.
Mult Scler Relat Disord. 2022.
PMID: 36174323
Free article.
Review.
Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data.
Lübbert C, Dykukha I, Pelz JP, Yearley H, Junker W, Gruber N, Escher S, Biereth K, Melnik S, Puschmann J.
Lübbert C, et al. Among authors: dykukha i.
Drugs Context. 2023 Jun 27;12:2023-3-4. doi: 10.7573/dic.2023-3-4. eCollection 2023.
Drugs Context. 2023.
PMID: 37415918
Free PMC article.
Review.
Item in Clipboard
Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials.
Dykukha I, Malessa R, Essner U, Überall MA.
Dykukha I, et al.
Pain Med. 2021 Apr 20;22(4):861-874. doi: 10.1093/pm/pnab050.
Pain Med. 2021.
PMID: 33561282
Item in Clipboard
Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?
Vila Silván C, Vaney C, Dykukha I.
Vila Silván C, et al. Among authors: dykukha i.
Expert Rev Clin Pharmacol. 2022 Apr;15(4):415-431. doi: 10.1080/17512433.2022.2088501. Epub 2022 Aug 3.
Expert Rev Clin Pharmacol. 2022.
PMID: 35679523
Item in Clipboard
Application of the Statistical Method to Convert Published PASI 50/75/90/100 into Absolute PASI Response Rate in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab Based on Data from the Two Pivotal Phase 3 Studies reSURFACE 1 and reSURFACE 2.
Dykukha I, Schoenenberger A, Kasujee I, Mrowietz U, Vonthein R.
Dykukha I, et al.
Dermatology. 2022;238(5):910-918. doi: 10.1159/000522009. Epub 2022 Feb 15.
Dermatology. 2022.
PMID: 35168231
Clinical Trial.
Item in Clipboard
Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Heppt MV, Dykukha I, Graziadio S, Salido-Vallejo R, Chapman-Rounds M, Edwards M.
Heppt MV, et al. Among authors: dykukha i.
J Clin Med. 2022 Mar 16;11(6):1654. doi: 10.3390/jcm11061654.
J Clin Med. 2022.
PMID: 35329979
Free PMC article.
Item in Clipboard
Cite
Cite